Platelet Biology in Focus – Current Opinion in Hematology 2026
Dianne E. van der Wal, Researcher at ANZAC Research Institute (Sydney Local Health District), shared a post by Current Opinion in Hematology on LinkedIn:
”Another great selection of platelet papers.”
Quoting Current Opinion in Hematology’s post:
”As we come to the end of 2025 and look forward to seeing in the New Year, fancy an early look to 2026. Our January 2026 issue of Current Opinion in Hematology is here, with a focus on Platelet Biology.
Joseph Aslan from Oregon Health & Science University highlights recent studies of platelet proteomes and platelet function in development, aging, and disease. Insights emphasize that the platelet proteome encodes both physiologic adaptability and maladaptive responses in pathology.
Next, we have a review on cellular contributions to the pathogenesis of anti-platelet factor 4 disorders, by Jared Treverton, Mark Lychacz, Donald Arnold, and Ishac Nazy, McMaster University
Mariia (Masha) Naumenko et al. analyze established platelet isolation protocols, clarifying their rationale and key overlooked factors. Their review explores the potential of modern strategies and emerging technologies, particularly artificial intelligence, to transform platelet research.
And in the review ‘Platelet concentrates in periodontics: a journey through platelet-rich plasma, platelet-rich fibrin and their therapeutic uses: a literature update’, Supreet Kaur et al. emphasize the pivotal function of platelet concentrates in advancing regenerative periodontal therapy. The authors conclude that concentrates offer a transformative advancement in periodontal therapy, leveraging the body’s natural healing processes to achieve superior clinical outcomes.
Full TOC here.
Thank you to our authors for their contributions, and to our Section Editors Joshua Mui and Colin Kretz for their hard work on bringing together this great section.
Wishing you all a wonderful festive season, and thank you for your support for the journal. Looking forward to sharing more important and insightful content with you next year.”

Keep up with Hemostasis Today.
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week